Log in to save to my catalogue

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with...

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4875067

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

About this item

Full title

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

Publisher

New York: Springer US

Journal title

Breast cancer research and treatment, 2016-06, Vol.157 (2), p.363-371

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Although Ki67 index suffers from poor reproducibility, it is one of the most important prognostic markers used by oncologists to select the treatment of estrogen receptor (ER) positive breast cancer patients. In this study, we aim to establish the optimal Ki67 cut-offs for stratifying patient prognosis and to create a comprehensive prognostic index...

Alternative Titles

Full title

Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4875067

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4875067

Other Identifiers

ISSN

0167-6806

E-ISSN

1573-7217

DOI

10.1007/s10549-016-3817-9

How to access this item